Twitter gains users, beats estimates but ad trends alarm investors
Twitter Inc on Thursday reported higher first-quarter revenue and a smaller loss than analysts had expected amid the coronavirus pandemic, but its shares fell as...
Macy’s to reopen 68 stores, targets all within six weeks
Macy’s Inc plans to reopen 68 U.S. stores on Monday in states that have loosened coronavirus lockdowns, the department store operator said on Thursday, as...
Poland’s Supreme Court chief and top government critic retires
Poland’s Supreme Court chief Malgorzata Gersdorf ended a six-year term on Thursday, opening the way for the ruling nationalists to pick a supporter of their...
Canadian military helicopter crashes in Mediterranean: NATO
A Canadian military helicopter crashed in the Mediterranean off the coast of Greece on Wednesday, prompting a search and rescue mission, NATO said in a...
Exclusive: India, Pakistan nuclear procurement networks larger than thought, study shows
Hundreds of foreign companies are actively procuring components for India and Pakistan’s nuclear programmes, taking advantage of gaps in the global regulation of the industry,...
ConocoPhillips to sharply cut oil production as low prices hit earnings
U.S. oil and gas company ConocoPhillips said on Thursday it would sharply reduce oil production in coming weeks, aiming to shut in 35% of its...
Oil prices set to cap off nightmare month with gains
Oil prices jumped for a second day on Thursday, lifted by signs the U.S. crude glut is not growing as quickly as expected and clawing...
Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020 depending on trials
Pfizer aims to make 10-20 million doses of a coronavirus vaccine it is developing with Germany’s BioNtech by the end of 2020 for possible emergency...
Moscow doctor sees echoes of war in coronavirus battle
When patients who can hardly breathe fill the wards of Moscow Hospital Number 52, Mikhail Ketskalo recalls the suffering he witnessed as a military doctor...
U.S. FDA moving with ‘lightning speed’ on Gilead’s COVID-19 drug: Bloomberg
The U.S. Food and Drug Administration is working at “lightning speed” to review data on Gilead Sciences Inc’s experimental antiviral drug remdesivir in treating COVID-19...
